|
Stevanato -Gruppe S.P.A. (STVN) DCF -Bewertung
IT | Healthcare | Medical - Instruments & Supplies | NYSE
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Stevanato Group S.p.A. (STVN) Bundle
Entdecken Sie die finanzielle Zukunft der Stevanato Group S.P.A. (STVN) mit unserem benutzerfreundlichen DCF-Taschenrechner! Geben Sie Ihre Projektionen für Wachstum, Margen und Kosten ein, um den inneren Wert der Stevanato -Gruppe S.P.A. (STVN) zu berechnen und Ihre Anlagestrategie zu verbessern.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 556.7 | 686.9 | 875.5 | 1,020.6 | 1,126.0 | 1,344.9 | 1,606.4 | 1,918.7 | 2,291.7 | 2,737.2 |
| Revenue Growth, % | 0 | 23.39 | 27.47 | 16.57 | 10.33 | 19.44 | 19.44 | 19.44 | 19.44 | 19.44 |
| EBITDA | 110.5 | 162.2 | 235.4 | 266.0 | 282.6 | 326.9 | 390.4 | 466.3 | 557.0 | 665.3 |
| EBITDA, % | 19.86 | 23.62 | 26.89 | 26.06 | 25.09 | 24.3 | 24.3 | 24.3 | 24.3 | 24.3 |
| Depreciation | 47.8 | 52.1 | 59.8 | 66.0 | 81.4 | 98.7 | 117.9 | 140.8 | 168.2 | 200.9 |
| Depreciation, % | 8.59 | 7.58 | 6.83 | 6.47 | 7.23 | 7.34 | 7.34 | 7.34 | 7.34 | 7.34 |
| EBIT | 62.7 | 110.1 | 175.6 | 200.0 | 201.1 | 228.2 | 272.5 | 325.5 | 388.8 | 464.3 |
| EBIT, % | 11.27 | 16.04 | 20.06 | 19.6 | 17.86 | 16.96 | 16.96 | 16.96 | 16.96 | 16.96 |
| Total Cash | 131.0 | 163.0 | 454.6 | 266.3 | 74.9 | 354.9 | 423.9 | 506.3 | 604.7 | 722.3 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 197.8 | 203.2 | 235.9 | 328.0 | 492.1 | 451.7 | 539.5 | 644.3 | 769.6 | 919.2 |
| Account Receivables, % | 35.54 | 29.58 | 26.95 | 32.14 | 43.7 | 33.58 | 33.58 | 33.58 | 33.58 | 33.58 |
| Inventories | 136.8 | 144.6 | 154.5 | 221.3 | 264.9 | 291.8 | 348.5 | 416.3 | 497.2 | 593.9 |
| Inventories, % | 24.58 | 21.05 | 17.64 | 21.68 | 23.52 | 21.7 | 21.7 | 21.7 | 21.7 | 21.7 |
| Accounts Payable | 98.6 | 123.2 | 171.0 | 248.1 | 288.2 | 282.7 | 337.6 | 403.3 | 481.7 | 575.3 |
| Accounts Payable, % | 17.72 | 17.94 | 19.53 | 24.31 | 25.6 | 21.02 | 21.02 | 21.02 | 21.02 | 21.02 |
| Capital Expenditure | -76.7 | -99.6 | -117.4 | -252.2 | -458.5 | -288.1 | -344.2 | -411.1 | -491.0 | -586.4 |
| Capital Expenditure, % | -13.77 | -14.5 | -13.41 | -24.72 | -40.72 | -21.42 | -21.42 | -21.42 | -21.42 | -21.42 |
| Tax Rate, % | 23.17 | 23.17 | 23.17 | 23.17 | 23.17 | 23.17 | 23.17 | 23.17 | 23.17 | 23.17 |
| EBITAT | 44.9 | 89.8 | 142.4 | 152.3 | 154.5 | 176.7 | 211.1 | 252.1 | 301.1 | 359.6 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -220.0 | 53.8 | 89.9 | -115.7 | -390.2 | -4.7 | -104.8 | -125.1 | -149.5 | -178.5 |
| WACC, % | 6.38 | 6.41 | 6.41 | 6.4 | 6.4 | 6.4 | 6.4 | 6.4 | 6.4 | 6.4 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -448.4 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -182 | |||||||||
| Terminal Value | -4,138 | |||||||||
| Present Terminal Value | -3,035 | |||||||||
| Enterprise Value | -3,483 | |||||||||
| Net Debt | 339 | |||||||||
| Equity Value | -3,822 | |||||||||
| Diluted Shares Outstanding, MM | 265 | |||||||||
| Equity Value Per Share | -14.42 |
What You Will Get
- Real STVN Financial Data: Pre-filled with Stevanato Group’s historical and projected data for precise analysis.
- Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
- Automatic Calculations: See Stevanato Group’s intrinsic value update instantly based on your changes.
- Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
- User-Friendly Design: Simple structure and clear instructions for all experience levels.
Key Features
- Comprehensive Historical Data: Stevanato Group’s past financial statements and pre-populated projections.
- Customizable Parameters: Modify WACC, tax rates, revenue growth, and EBITDA margins as needed.
- Real-Time Calculations: View Stevanato Group’s intrinsic value update instantly.
- Intuitive Visual Representations: Dashboard graphs showcase valuation outcomes and essential metrics.
- Engineered for Precision: A reliable tool designed for analysts, investors, and finance professionals.
How It Works
- Step 1: Download the Excel file for Stevanato Group S.p.A. (STVN).
- Step 2: Review the pre-filled financial data and forecasts for Stevanato Group.
- Step 3: Modify key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Observe the DCF model update in real-time as you adjust your assumptions.
- Step 5: Analyze the results and utilize the outputs for your investment decisions.
Why Choose This Calculator for Stevanato Group S.p.A. (STVN)?
- Accurate Data: Real Stevanato Group financials provide trustworthy valuation outcomes.
- Customizable: Modify essential parameters such as growth rates, WACC, and tax rates to fit your forecasts.
- Time-Saving: Pre-built calculations save you from building models from the ground up.
- Professional-Grade Tool: Tailored for investors, analysts, and consultants in the industry.
- User-Friendly: Clear layout and step-by-step guidance ensure accessibility for all users.
Who Should Use Stevanato Group S.p.A. (STVN)?
- Investors: Make informed investment choices with insights from a leading player in the pharmaceutical packaging sector.
- Financial Analysts: Streamline your analysis with comprehensive data on market trends and company performance.
- Consultants: Efficiently tailor presentations or reports using detailed information on Stevanato Group’s offerings.
- Industry Enthusiasts: Enhance your knowledge of the pharmaceutical supply chain and packaging innovations.
- Educators and Students: Utilize it as a case study in business and finance courses focusing on the healthcare industry.
What the Template Contains
- Pre-Filled Data: Includes Stevanato Group S.p.A.'s historical financials and forecasts.
- Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
- Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
- Key Financial Ratios: Analyze Stevanato Group S.p.A.'s profitability, efficiency, and leverage.
- Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
- Clear Dashboard: Charts and tables summarizing key valuation results.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.